The pandemic has made this comeback theater season an unusually rocky one. After a joyous reopening following the long, painful shutdown, the Omicron surge led to a ton of holiday closings, and another spike in positive cases this spring led to a rolling wave of performer absences and occasional show cancellations.
That disruption was upsetting for artists and fans, and damaging for producers and investors.
It also posed an unprecedented complication for Tony nominators, who are not only required to see every eligible production, but also to see the performances of all Tony-eligible actors.
That’s always hard — most of the nominators have day jobs, and some of them live outside New York, and many shows have limited runs. But this season, two factors made it even harder: a higher-than-normal number of shows opened in April, just before the deadline to be eligible for a Tony, and the spike in spring cases meant that key actors often missed performances. (Among the possible nominees who tested positive for the coronavirus near the season’s end: Daniel Craig, Sarah Jessica Parker, Matthew Broderick, Laurence Fishburne and Ramin Karimloo. Plus: Billy Crystal canceled two performances of “Mr. Saturday Night,” citing the flu.)
For nominators, that made the ordinary complexity of end-of-season scheduling far trickier — so difficult, in fact, that the Tony administrators wound up delaying the nominations by six days to give the nominators more time to see shows.
Even so, the number of nominators who managed to get to the finish line is low. There are usually about 50 nominators per season, some of whom wind up recusing themselves when a conflict of interest develops; this season there were just 29 who were able to participate in the voting.
Source: Theater - nytimes.com
